These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32620642)

  • 41. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
    Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
    Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
    Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
    Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Helicobacter pylori and gastroesophageal reflux disease.
    Kandulski A; Malfertheiner P
    Curr Opin Gastroenterol; 2014 Jul; 30(4):402-7. PubMed ID: 24848647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different histological status of gastritis in superficial adenocarcinoma of the esophagogastric junction.
    Yamada M; Kushima R; Oda I; Mojtahed K; Nonaka S; Suzuki H; Yoshinaga S; Matsubara A; Taniguchi H; Sekine S; Saito Y; Shimoda T
    Jpn J Clin Oncol; 2014 Jan; 44(1):65-71. PubMed ID: 24220802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus.
    Loffeld RJ; Werdmuller BF; Kuster JG; Pérez-Pérez GI; Blaser MJ; Kuipers EJ
    Digestion; 2000; 62(2-3):95-9. PubMed ID: 11025356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pathogenesis of esophageal cancer from reflux esophagitis].
    Kawano T; Nakajima Y; Kawada K
    Nihon Rinsho; 2016 Aug; 74(8):1393-1400. PubMed ID: 30562449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Barrett's esophagus.
    Shalauta MD; Saad R
    Am Fam Physician; 2004 May; 69(9):2113-8. PubMed ID: 15152957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular mechanisms of acid exposure in Barrett's esophagus.
    Souza RF
    Inflammopharmacology; 2007 Jun; 15(3):95-100. PubMed ID: 19847948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mott cell (Russell bodies) Barrett's oesophagitis.
    Rubio CA
    In Vivo; 2005; 19(6):1097-100. PubMed ID: 16277029
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can endoscopy tell us anything about GERD in the absence of esophagitis or Barrett's esophagus?
    DeVault KR
    Gastrointest Endosc; 2006 Jan; 63(1):32-4. PubMed ID: 16377312
    [No Abstract]   [Full Text] [Related]  

  • 52. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
    Stein HJ; Kauer WK; Feussner H; Siewert JR
    J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathophysiology of Barrett's esophagus.
    Chandrasoma P
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):270-8. PubMed ID: 9263345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical management of Barrett's esophagus.
    Clark GW; DeMeester TR
    Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Barrett esophagus and inflammation of gastroesophageal junction].
    Voutilainen M; Färkkilä M; Sipponen P
    Duodecim; 2000; 116(17):1899-905. PubMed ID: 12001646
    [No Abstract]   [Full Text] [Related]  

  • 58. Barrett's esophagus: a review.
    Sjogren RW; Johnson LF
    Am J Med; 1983 Feb; 74(2):313-21. PubMed ID: 6337489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.
    DeMeester SR; Wickramasinghe KS; Lord RV; Friedman A; Balaji NS; Chandrasoma PT; Hagen JA; Peters JH; DeMeester TR
    Am J Gastroenterol; 2002 Oct; 97(10):2514-23. PubMed ID: 12385432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux.
    Hamilton SR; Hutcheon DF; Ravich WJ; Cameron JL; Paulson M
    Gastroenterology; 1984 Feb; 86(2):356-60. PubMed ID: 6690363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.